Praxis Has Unexpected Hits In Two Phase II Essential Tremor Studies

 
• By Joseph Haas
  
Surprise
Praxis surprised investors with positive data from two Phase III studies in essential tremor • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D